Nothing Special   »   [go: up one dir, main page]

Howson et al., 2015 - Google Patents

MR1-restricted mucosal-associated invariant T cells and their activation during infectious diseases

Howson et al., 2015

View HTML
Document ID
16942318279079552809
Author
Howson L
Salio M
Cerundolo V
Publication year
Publication venue
Frontiers in Immunology

External Links

Snippet

MR1-restricted mucosal-associated invariant T (MAIT) cells recognize vitamin B metabolites, which are generated by a broad range of bacteria, from Escherichia coli to Mycobacterium tuberculosis and BCG. MAIT cells have been described as innate sensors of infection as …
Continue reading at www.frontiersin.org (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria

Similar Documents

Publication Publication Date Title
Howson et al. MR1-restricted mucosal-associated invariant T cells and their activation during infectious diseases
Li et al. TCR transgenic mice reveal stepwise, multi-site acquisition of the distinctive fat-Treg phenotype
Goettel et al. AHR activation is protective against colitis driven by T cells in humanized mice
Ioannidis et al. The immune modulating properties of mucosal-associated invariant T cells
Meermeier et al. MAIT cells and microbial immunity
Buettner et al. Development and function of secondary and tertiary lymphoid organs in the small intestine and the colon
Dhamne et al. Peripheral and thymic foxp3+ regulatory T cells in search of origin, distinction, and function
Abina et al. Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome
Mayer et al. CD8+ Foxp3+ T cells share developmental and phenotypic features with classical CD4+ Foxp3+ regulatory T cells but lack potent suppressive activity
Le Bourhis et al. MAIT cells detect and efficiently lyse bacterially-infected epithelial cells
Mun et al. TLR2 as an essential molecule for protective immunity against Toxoplasma gondii infection
Pak-Wittel et al. Interferon-γ mediates chemokine-dependent recruitment of natural killer cells during viral infection
Xiao et al. Mucosal-associated invariant T cells: new insights into antigen recognition and activation
Patterson et al. T regulatory cell chemokine production mediates pathogenic T cell attraction and suppression
Parekh et al. Activated invariant NKT cells control central nervous system autoimmunity in a mechanism that involves myeloid-derived suppressor cells
Beigier-Bompadre et al. Mycobacterium tuberculosis infection modulates adipose tissue biology
Ghazarian et al. Mucosal-associated invariant T cell interactions with commensal and pathogenic bacteria: potential role in antimicrobial immunity in the child
Corbett et al. Antigen recognition by MR1-reactive T cells; MAIT cells, metabolites, and remaining mysteries
Parisi et al. Natural killer cells in the orchestration of chronic inflammatory diseases
Dias et al. Factors influencing functional heterogeneity in human mucosa-associated invariant T cells
Sun et al. Two to tango: dialogue between adaptive and innate immunity in type 1 diabetes
Sun et al. RORγt represses IL-10 production in Th17 cells to maintain their pathogenicity in inducing intestinal inflammation
Yu et al. Differentiation of IL-17-producing invariant natural killer T cells requires expression of the transcription factor c-Maf
Huang et al. The role of CD1d and MR1 restricted T cells in the liver
Hofer et al. Comparative analysis of T-cell responses to aquaporin-4 and myelin oligodendrocyte glycoprotein in inflammatory demyelinating central nervous system diseases